Shanghai Pharmaceuticals Holding Co., Ltd SHPMY
$7.24
-$0.15-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.76% | 6.28% | 3.12% | 2.87% | 3.95% |
| Total Other Revenue | 7.31% | -2.09% | -2.09% | -6.56% | 3.88% |
| Total Revenue | 7.76% | 6.25% | 3.10% | 2.84% | 3.95% |
| Cost of Revenue | 7.32% | 6.14% | 3.49% | 3.41% | 4.70% |
| Gross Profit | 11.48% | 7.14% | -0.01% | -1.80% | -1.99% |
| SG&A Expenses | 10.87% | 10.24% | 2.13% | -1.46% | -3.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4,249.43% | 264.62% | 254.06% | -76.96% | -102.83% |
| Total Operating Expenses | 7.84% | 6.48% | 3.48% | 2.85% | 3.82% |
| Operating Income | 5.17% | -0.54% | -7.66% | 2.25% | 8.01% |
| Income Before Tax | -10.37% | 31.91% | 22.25% | 34.26% | 36.41% |
| Income Tax Expenses | -12.98% | 39.28% | 32.37% | 45.85% | 37.87% |
| Earnings from Continuing Operations | -9.38% | 29.15% | 18.55% | 29.96% | 35.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.82% | -7.79% | 4.95% | 2.09% | 3.79% |
| Net Income | -17.92% | 35.56% | 25.35% | 39.59% | 47.92% |
| EBIT | 5.17% | -0.54% | -7.66% | 2.25% | 8.01% |
| EBITDA | 6.28% | 2.27% | -4.35% | 4.02% | 8.83% |
| EPS Basic | -17.81% | 36.10% | 25.38% | 40.04% | 46.95% |
| Normalized Basic EPS | -30.66% | 41.51% | 36.76% | 62.34% | 71.18% |
| EPS Diluted | -17.88% | 36.05% | 25.29% | 40.33% | 47.94% |
| Normalized Diluted EPS | -30.66% | 41.51% | 36.76% | 62.34% | 71.18% |
| Average Basic Shares Outstanding | 0.05% | -0.13% | 0.11% | -0.93% | 0.09% |
| Average Diluted Shares Outstanding | 0.05% | -0.13% | 0.11% | -0.93% | 0.09% |
| Dividend Per Share | 12.65% | 28.65% | 28.65% | -16.08% | -16.08% |
| Payout Ratio | 0.04% | -0.32% | -0.38% | -0.41% | -0.41% |